+966 568813716 [email protected]

Articles

Home / Archive by category "Articles" (Page 2)
21
Nov
2024
What are the biggest mistakes Psychiatrist should not make?
Posted On November 21, 2024  By [email protected]  And has No Comment

Here are some of the most critical mistakes psychiatrists should avoid: The Ten Biggest Mistakes Psychiatrists Make Long but necessary. 1. Talk too much  It’s not a conversation, and it’s not a debate.  You are either treating their symptoms with medication, or guiding them to “treat” their […]

Read More

20
Nov
2024
Mr. Sick leave in Psychiatric Clinic
Posted On November 20, 2024  By [email protected]  And has No Comment

sick leave among psychiatric patient ?Edit Let me help you analyze the topic of sick leave among psychiatric patients. Let me break this down into key aspects: Would you like me to elaborate on any particular aspect of this topic? I can provide more detailed information […]

Read More

05
Nov
2024
Anhedonia
Posted On November 5, 2024  By [email protected]  And has No Comment

Anhedonia is a core symptom of depression and other mental health conditions, characterized by the diminished ability to experience pleasure or engage in activities that were previously enjoyable. Understanding the meaning, discovery, and reporting of anhedonia is important for both psychiatric and medical patients. Let’s explore […]

Read More

05
Nov
2024
Vortioxetine Administration and Effects?
Posted On November 5, 2024  By [email protected]  And has No Comment

The time course of vortioxetine effects is an important aspect of its pharmacological profile. Vortioxetine is a multimodal antidepressant that works through several mechanisms, including serotonin reuptake inhibition and modulation of various serotonin receptors. Let us break down the time course of its effects: Time Course […]

Read More

08
Oct
2024
Venlafaxine: unleashed Secrets
Posted On October 8, 2024  By [email protected]  And has No Comment

The story behind discovery 1993: The immediate-release form of venlafaxine (Effexor®), a serotonin-norepinephrine reuptake inhibitor (SNRI), was approved by the FDA for the treatment of major depressive disorder (MDD) in the United States.1997:The extended-release form of venlafaxine was also approved for MDD treatment.Key MilestonesIntroduction of the […]

Read More

23
Sep
2024
Clozapine and Obsessions?
Posted On September 23, 2024  By [email protected]  And has No Comment

does clozapine increase obsessions? Clozapine is an atypical antipsychotic medication primarily used to treat schizophrenia, particularly in cases that have not responded well to other treatments. Its effects on obsessions are somewhat complex: It’s crucial for patients to communicate any new or worsening symptoms to their […]

Read More

18
Sep
2024
Adding more Sex Potency
Posted On September 18, 2024  By [email protected]  And has No Comment

how to increase or augment sexual desire and erection in non diabetic , non hypertensive old man There are several ways to potentially increase sexual desire and improve erectile function in older men without diabetes or hypertension. Here are some evidence-based approaches: It’s important to consult […]

Read More

06
Sep
2024
Amphetamine-Linked Priapism Risks
Posted On September 6, 2024  By [email protected]  And has No Comment

Emergency for amphetamine users Priapism, a persistent and painful erection lasting more than 4 hours, has been linked to amphetamine misuse. This condition is often associated with the use of stimulant medications, including amphetamines, for attention-deficit/hyperactivity disorder (ADHD) in children. Crystal methamphetamine (crystal meth) can indeed induce […]

Read More

02
Aug
2024
Esketamine nasal spray: New hope for resistant depression
Posted On August 2, 2024  By [email protected]  And has No Comment

On March 05, 2019 The U.S. Food and Drug Administration approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepresant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk […]

Read More

02
Aug
2024
Buvidal : a new hope for opiate addiction?
Posted On August 2, 2024  By [email protected]  And has No Comment

What is Opioid Agonist Treatment (OAT)? Here’s a general medical protocol for using Buvidal (long-acting buprenorphine) in a day case hospitalization setting for an opioid-dependent patient. Please note that this should be adapted based on specific institutional guidelines and individual patient needs. Suggested Protocol for Buvidal […]

Read More


Page 2 of 54